RecruitingNCT03303716

ASXL-Related Disorders Natural History Study

Natural History Study for the ASXL-Related Disorders and Chromatinopathies


Sponsor

University of California, Los Angeles

Enrollment

200 participants

Start Date

Sep 20, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).


Eligibility

Inclusion Criteria1

  • Clinical or molecular diagnosis of an ASXL related disorder

Exclusion Criteria1

  • No clinical or molecular diagnosis of an ASXL related disorder

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of California, Los Angeles

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03303716


Related Trials